SCHEMBL29567201

SCHEMBL29567201

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2ccc(F)c(N3CCN(C)CC3)c2)c1C(F)(F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 1/20 0.33
▸ BRAF P15056 1/20 0.32
▸ TACR1 P25103 2/20 0.32
▸ BRD4 O60885 3/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ BRDT Q58F21 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ EGFR P00533 2/20 0.31
▸ MET P08581 2/20 0.31
▸ INSR P06213 1/20 0.31
▸ MAPT P10636 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310787 1.00 AXL (0.33) AXLBRAFTACR1BRD4JAK2
SCHEMBL24310777 0.90 HTR1A (0.38) TACR1BRD4JAK2JAK3EGFR
SCHEMBL29566715 0.90 HTR1A (0.38) TACR1BRD4JAK2JAK3EGFR
SCHEMBL29566963 0.89 RAD52 (0.36) TACR1BRD4JAK2FLT3JAK1
SCHEMBL24310187 0.89 RAD52 (0.36) TACR1BRD4JAK2FLT3JAK1
SCHEMBL24310497 0.88 RAD52 (0.36) BRD4JAK3EGFRMETINSR
SCHEMBL29566997 0.88 RAD52 (0.34) TACR1BRD4JAK2ALDH1A1TP53
SCHEMBL24310530 0.88 RAD52 (0.34) TACR1BRD4JAK2ALDH1A1TP53
SCHEMBL29567137 0.88 RAD52 (0.36) BRD4JAK3EGFRMETINSR
SCHEMBL29567138 0.88 RAD52 (0.36) BRD4JAK3EGFRMETINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback